{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:39:06Z","timestamp":1785829146955,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.drugalcdep.2016.11.037","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T19:15:57Z","timestamp":1484162157000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release"],"prefix":"10.1016","volume":"172","author":[{"given":"Michael S.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Kinlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence T.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Vocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2016.11.037_bib0005","first-page":"126","article-title":"Feasibility of Initiating Treatment with Buprenorphine-Naloxone in a state prison for opiate dependent inmates nearing release","volume":"1","author":"Albizu-Garcia","year":"2007","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(99)00074-5","article-title":"Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet","volume":"58","author":"Amass","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.11.029","article-title":"Risk factors for all-cause, overdose and early deaths after release from prison in Washington state","volume":"117","author":"Binswanger","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2007.11.019","article-title":"Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention","volume":"19","author":"Bruce","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0030","unstructured":"Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse and addiction in the criminal justice system: improving public health and safety","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0040","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/10826089909039401","article-title":"Gender differences at admission and follow-up in a sample of methadone maintenance clients","volume":"34","author":"Chatham","year":"1999","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0045","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0050","first-page":"871","article-title":"Buprenorphine\/naloxone versus methadone in opioid dependence: a longitudinal survey","volume":"15","author":"Curcio","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/add.12337","article-title":"Causes of death in a cohort treated for opioid dependence between 1985 and 2005","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0065","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","article-title":"Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality re-incarceration and hepatitis C infection","volume":"100","author":"Dolan","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0070","series-title":"Prisons and Drugs: A Global Review of Incarceration, Drug Use and Drug Services","author":"Dolan","year":"2007"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0075","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","article-title":"Methadone treatment of randomly selected criminal addicts","volume":"280","author":"Dole","year":"1969","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1360-0443.2007.02081.x","article-title":"Acute risk of drug-related death among newly released prisoners in England and Wales","volume":"103","author":"Farrell","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0085","first-page":"w13898","article-title":"Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland","volume":"143","author":"Favrod-Coune","year":"2013","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: a systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/ADM.0b013e31814b8880","article-title":"Buprenorphine-naloxone treatment for pre-release opioid-dependent inmate in Puerto Rico","volume":"1","author":"Garcia","year":"2007","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0105","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","article-title":"A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release","volume":"103","author":"Gordon","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/bsl.1015","article-title":"Medication-assisted treatment research with criminal justice populations: challenges of implementation","volume":"29","author":"Gordon","year":"2011","journal-title":"Behav. Sci. Law"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/10509674.2013.801386","article-title":"Gender differences among prisoners with pre-incarceration heroin dependence participating in a randomized clinical trial of buprenorphine treatment","volume":"52","author":"Gordon","year":"2013","journal-title":"J. Offend. Rehab."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00952999009001585","article-title":"Trends in criminal activity and drug use over an addiction career","volume":"16","author":"Hanlon","year":"1990","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1081\/JA-120004162","article-title":"Drug user treatment within a criminal justice context","volume":"37","author":"Hough","year":"2002","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0135","series-title":"The War on Drugs IV: The Continuing Saga of the Mysteries and Miseries of Intoxication, Addiction, Crime and Public Policy","author":"Inciardi","year":"2008"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/YCO.0b013e3282fc985c","article-title":"Drug use and health among prison inmates","volume":"21","author":"Kanato","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0145","series-title":"Opioid Substitution Treatment in Custodial Settings. A Practical Guide","author":"Kastelic","year":"2008"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0150","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/002204260303300406","article-title":"Prediction of the criminal activity of incarcerated drug-abusing offenders","volume":"33","author":"Kinlock","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release","volume":"91","author":"Kinlock","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0093854807309111","article-title":"A study of methadone maintenance for male prisoners: 3-month post-release outcomes","volume":"35","author":"Kinlock","year":"2008","journal-title":"Crim. Justice Behav."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months post-release","volume":"37","author":"Kinlock","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10509670903534951","article-title":"Developing and implementing a new prison-based buprenorphine treatment program","volume":"49","author":"Kinlock","year":"2010","journal-title":"J. Offender Rehab."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0175","series-title":"Lowinson and Ruiz\u2019s Substance Abuse: A Comprehensive Textbook","first-page":"881","article-title":"Incarcerated populations","author":"Kinlock","year":"2011"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/PAF.0b013e3181873784","article-title":"Drugs, detention, and death: a study of the mortality of recently released prisoners","volume":"30","author":"Krinsky","year":"2009","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwr327","article-title":"Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001\u20132005","volume":"175","author":"Lim","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0195","series-title":"SAS for Mixed Models","author":"Littell","year":"2006"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0200","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1360-0443.1993.tb02021.x","article-title":"HIV risk among women injecting drug users who are in jail","volume":"88","author":"Magura","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0210","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1360-0443.2009.02558.x","article-title":"Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003\u201306)","volume":"104","author":"Marzo","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0215","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev. (Online)"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0220","series-title":"Generalized Linear Models","author":"McCullagh","year":"1989"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5055\/jom.2009.0024","article-title":"Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice","volume":"5","author":"McKenzie","year":"2009","journal-title":"J. Opioid Manage."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08897077.2011.609446","article-title":"A randomized trial of methadone initiation prior to release from incarceration","volume":"33","author":"McKenzie","year":"2012","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0240","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0245","first-page":"5","article-title":"Evaluation of opioid-dependent prisoners in oral opioid maintenance therapy","volume":"12","author":"Metz","year":"2010","journal-title":"Heroin Addict. Rel. Clin."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0255","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3109\/10826089809059323","article-title":"A long-term program of research on drug use and crime","volume":"33","author":"Nurco","year":"1998","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O\u2019Connor","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0270","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0740-5472(99)00091-4","article-title":"Services provided during methadone treatment: a gender comparison","volume":"19","author":"Rowan-Szal","year":"2000","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archinte.161.1.85","article-title":"Benefits of linking primary medical care and substance abuse services: patient provider, and societal perspectives","volume":"161","author":"Samet","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0280","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsat.2009.05.003","article-title":"Buprenorphine maintenance treatment in a primary care setting: outcomes at 1year","volume":"37","author":"Soeffing","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0285","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/add.12613","article-title":"Commentary on Degenhardt et al., 2014: access to opioid substitution therapy in prison is not enough-the crucial role of post-release retention in preventing drug-related harms","volume":"109","author":"Stoove","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-7-17","article-title":"Drug use and opioid substitution treatment for prisoners","volume":"7","author":"Stover","year":"2010","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0295","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1360-0443.2006.01475.x","article-title":"Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin cocaine and amphetamine in prison","volume":"101","author":"Strang","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0300","series-title":"Mixed Model Procedures to Assess Power, Precision, and Sample Size in the Design of Experiments","first-page":"19","author":"Stroup","year":"1999"},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0310","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsat.2006.12.019","article-title":"Drug treatment services for adult offenders: the state of the state","volume":"32","author":"Taxman","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2015.09.001","article-title":"Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners","volume":"156","author":"Vocci","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.11.037_bib0320","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"Zaller","year":"2013","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617300078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617300078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:59:29Z","timestamp":1568721569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617300078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":64,"alternative-id":["S0376871617300078"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.037","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}